SHANGHAI, China, May 29, 2018 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:
- Jefferies 2018 Global Healthcare Conference in New York on Thursday, June 7th. Dr. Samantha Du, CEO of Zai Lab, will present at 10:00am ET.
- Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Wednesday, June 13, 2018. Dr. Samantha Du, CEO of Zai Lab, will present at 2:00pm PT.
Individuals may access a live webcast of the Conference presentations on the Zai Lab website at www.zailaboratory.com under “Events & Presentations” in the “Investors” section. A replay of the webcast will be available on this site for 90 days following the live event.
About Zai Lab
Zai Lab (NASDAQ:ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners and its own products in order to impact human health worldwide.
Contact:
Zai Lab
Billy Cho
+86 137 6151 2501
billy.cho@zailaboratory.com
Media: Justin Jackson
Burns McClellan, on behalf of Zai Lab
212-213-0006, ext. 327, jjackson@burnsmc.com
Investors: Jill Steier
Burns McClellan, on behalf of Zai Lab
212-213-0006, ext. 367, jsteier@burnsmc.com
